1 July 2008 in Computational Materials Science
1 February 2012 in Computational Materials Science
1 January 2021 in Journal of Physics: Conference Series
This paper introduces the Type 1 Diabetes Simulator (T1DDS) and presents its potential in virtualization of type 1 diabetes mellitus therapy. The body of a person with type 1 diabetes does not produce insulin and this hormone must be supplied from the outside constantly to avoid death. Moreover, the insulin doses must be correct in order to minimize short- and long-term health complications. The dose determination is challenging due to the high dynamics of the insulin – glucose metabolic system. For the reason computer therapy aided systems have been developed for last decades to help solve the problem. Type 1 Diabetes Direct Simulator (T1DDS) is the author’s original computer program that imitates physiology of a type 1 diabetic. The aim of the simulator is to enable virtual medical interaction with such a patient within the scope of blood glucose level change after a meal intake and insulin administration. The paper illustrates the ideas behind the direct simulator. Describes and argues its model assumptions and explains its implementation. An exemplary application in medical education is presented and discussed as well.
1 January 2011 in Archives of Civil and Mechanical Engineering
1 June 2021 in Advances in Science and Technology Research Journal
3D printing of historic architectural objects reduces the entire digital model by up to 200 times. With this scaling of the digital 3D model, many important architectural and decorative details are lost, and some elements lose their stiffness. Printed 3D models are now used to create specialised...
1 September 2020 in Journal of Education, Health and Sport
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycaemia due to defective secretion and/or action of insulin. Chronic hyperglycaemia is associated with damage, dysfunction, and failure of various organs, in particular eyes, kidneys, nerves, heart, and blood vessels. It is estimated that the number of patients with type 1 diabetes accounts for about 10% of all diabetics, even more children and young adults i.e. under 30 constitute between 85 – 90 % of morbidities. The fundamental part of type 1 diabetes therapy is providingpatient with an external insulin therapy. The objective of this research was to formulate requirements concerning mobile applications for diabetes 1 therapy as well as an overview and a classification of such applications currently available. This paper includes a set of 20 requirementsfor mobile applications intended for type 1 diabetes patients. Some of them are beyond the possibilities of the modern-day IT industry. Nowadays there is no applications that meets all of the criteria. However, the tendency to fulfill all of them can be noticed.